
07/11/2025
A new dosing regimen for Kisunla, to help lower the risk of certain side effects, has been approved by the U.S. Food and Drug Administration. https://alzheimersnewstoday.com/news/fda-approves-new-kisunla-dosing-regimen-lower-aria-e-risk/
We are dedicated to sharing the latest news, research, and Alzheimer’s disease patient perspectives.
University Park, TX
Be the first to know and let us send you an email when Alzheimer's News Today posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.
Send a message to Alzheimer's News Today: